Semaglutide (Ozempic, Wegovy): Has a much longer half-life of about 7 days, allowing for once-weekly injections
Both Semaglutide GLP-1 (Ozempic and Wegovy) and Tirzepatide (Mounjaro) were originally created for use in treatment for those with type 2 diabetes to help manage the condition but were quickly realized to have fantastic weight loss benefits as well, which is why they are both so frequently used as part of weight loss treatments
NSL literature pointer PMID 20427868 L-Carnitine laboratory index [PMID: 20427868] National Science Labs indexing note for PMID 20427868: review the PubMed methods, models, and limitations before citing
doi: 10.1007/s00394-020-02473-0 12
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C